Who are Asparagic Acid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Nutrestore, Sinemet Cr, Inbrija, L- DOPA, L-Arginine, L-Serine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/aspartic-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Asparagic Acid — Competitive Intelligence Brief

Asparagic Acid (ASPARTIC ACID) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino Acid [EPC]. Area: Metabolic.

marketed Amino Acid [EPC] Excitatory amino acid transporter 1 Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Asparagic Acid (ASPARTIC ACID).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Asparagic Acid TARGET	ASPARTIC ACID		marketed	Amino Acid [EPC]	Excitatory amino acid transporter 1
Nutrestore	GLUTAMINE	Emmaus Medcl	marketed	Amino Acid [EPC]		2004-01-01
Sinemet Cr	CARBIDOPA	Aton	marketed	Aromatic Amino Acid [EPC]	Lysine-specific demethylase 4E	1975-01-01
Inbrija	LEVODOPA	Merz	marketed	Aromatic Amino Acid [EPC]	Tyrosine-protein kinase Fyn	1970-01-01
L- DOPA	L- DOPA	Shaare Zedek Medical Center	marketed	Aromatic Amino Acid [EPC]
L-Arginine	L-Arginine	The University of Texas at Arlington	marketed	Amino acid supplement	Nitric oxide synthase substrate
L-Serine	L-Serine	Elijah W. Stommel	marketed	Amino acid supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2029-02-03 — Inbrija · RE43711 · Method of Use · US
2032-11-16 — Inbrija · 8685442 · Formulation · US
2032-11-16 — Inbrija · 8945612 · Formulation · US
2032-11-16 — Inbrija · 8545878 · Formulation · US
2032-11-16 — Inbrija · 9393210 · Formulation · US
2033-10-21 — Inbrija · 12458615 · Method of Use · US

Sponsor landscape (Amino Acid [EPC] class)

· 6 drugs in this class
Emmaus Medcl · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Asparagic Acid — Competitive Intelligence Brief. https://druglandscape.com/ci/aspartic-acid. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab